Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO We are not alone

It would appear that the MMP is not alone, having to aruge what should be obvious. Came across this Feb 26, 2010 PRECEDENTIAL opinion, based on a BPAI appeal. Let's hope that Kappos decides to rein in the convoluted broadest interpetation of everything and let common sense rule.

<The Examiner’s finding that Snabb discloses a meeting point located “substantially halfway” (Ans. 5) as claimed rests on an unreasonably broad interpretation of “substantially halfway”.>

Here is the link to the opinion,Opty

http://www.uspto.gov/ip/boards/bpai/decisions/prec/fd09006013.pdf

Share
New Message
Please login to post a reply